CC
DGX icon

Carlson Capital’s Quest Diagnostics DGX Stock Holding History

Carlson Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-208,625
Closed -$22.9M – 278
2018
Q2 		$22.9M Buy
+208,625
New +$21.7M 0.32% 83
2017
Q2 		– Sell
-164,825
Closed -$16.2M – 267
2017
Q1 		$16.2M Buy
+164,825
New +$15.7M 0.21% 138
2016
Q1 		– Sell
-202,400
Closed -$14.4M – 296
2015
Q4 		$14.4M Buy
+202,400
New +$13.6M 0.16% 167

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Carlson Capital's DGX Position: Q3 2018 in Review

Carlson Capital sold out of Quest Diagnostics (DGX) in Q3 2018, closing a stake of 208,625 shares — an estimated $22.9M sold.

Carlson Capital first reported a position in DGX in Q4 2015 and held it in 3 quarters. The position peaked at $22.9M in Q2 2018. 673 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

  • Carlson Capital reported no remaining Quest Diagnostics position as of Q3 2018 after selling out during the quarter.
  • Carlson Capital sold 208,625 Quest Diagnostics shares in Q3 2018, an estimated $22.9M.
  • Carlson Capital first reported a position in Quest Diagnostics in Q4 2015 and held it in 3 quarters.
  • Carlson Capital's Quest Diagnostics position peaked at $22.9M in Q2 2018.
  • 673 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on Carlson Capital's 13F filing for Q3 2018, filed 14 Nov 2018.